Stock listing

Tg Therapeutics, Inc.

Selected listing: NKB2 · MUN · EUR · DE

Tg Therapeutics, Inc. (Munich:NKB2), Health Technology. Latest release Sep 10, 2026: TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global…

NKB2:MUNEURDEUpdated September 25, 2026

Ticker: Munich:NKB2
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

About Tg Therapeutics, Inc.

The company focuses on developing innovative therapies for patients with cancer and autoimmune diseases. Tg Therapeutics is dedicated to advancing its research and development efforts to improve patient outcomes.

Latest news from Tg Therapeutics, Inc.

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 10, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 3, 2026

TG Therapeutics : Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

August 3, 2026

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

August 3, 2026

TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update

July 29, 2026

All Tg Therapeutics, Inc. news →

Events

Replays

TG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call
Mon, Aug 03, 2026 · 08:30 AM ET
Watch
TG Therapeutics, Inc. (TGTX) Q1 2026 Earnings Call
Wed, May 06, 2026 · 08:30 AM ET
Watch
TG Therapeutics, Inc. (TGTX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 AM ET
Watch

Research Tg Therapeutics, Inc.

Tg Therapeutics, Inc. company profile

View the public company page for Tg Therapeutics, Inc. on 6ix.

Tg Therapeutics, Inc. news

Read company news and market updates connected to Tg Therapeutics, Inc..

Tg Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Tg Therapeutics, Inc..